MSCA 是从候选名单中选择物质，还是进行分配？我们能否知道哪些 MSCA 会手动筛选我们的物质？注册人是否可以与评估机构进行面对面会谈，以澄清评估机构在对物质发表意见之前可能存在的一些问题？

MSCA 是从候选名单中选择物质，还是进行分配？我们能否知道哪些 MSCA 会手动筛选我们的物质？注册人是否可以与评估机构进行面对面会谈，以澄清评估机构在对物质发表意见之前可能存在的一些问题？

Do MSCAs select substances from the shortlist or are they allocated? Can we know which MSCAs manually screen our substances? Is it possible for the registrants to have a face to face meeting with the evaluating authority to clarify some question the evaluating MS may have before they render their opinion on the substance?

MSCA 会自行从候选名单中筛选物质，并非所有物质都一定会入选。如果物质种类繁多，两个或多个 MSCA 可以在手动筛选过程中进行协作。我们不会公布评估中的 MSCA，但每当针对某种物质启动监管活动时，启动该活动的成员国或机构都会在我们的网站上公布，并附上他们的联系方式。当针对某种物质启动监管行动时，如果由 MSCA 发起，可能会举行面对面会议，但在手动筛选过程中不会安排此类互动。

MSCAs make their own selection of the substances from the shortlist and not all substances are necessarily selected. In the case of large groups of substances, two or more MSCAs can collaborate during the manual screening. We don’t publish the evaluating MSCA but whenever a regulatory activity is initiated on a substance, the Member State or authority initiating the activity is published on our website, along with their contact details. When a regulatory action is started on a substance, a face-to-face meeting might be possible if initiated by the MSCA but no such interaction is foreseen during manual screening.